Next Article in Journal
Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines
Next Article in Special Issue
A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)
Previous Article in Journal
On the Regulatory Approval Pathway of Biosimilar Products
Previous Article in Special Issue
DNA Methylation as Clinically Useful Biomarkers—Light at the End of the Tunnel
 
 
Review

Article Versions Notes

Pharmaceuticals 2012, 5(4), 369-383; https://doi.org/10.3390/ph5040369
Action Date Notes Link
article html file updated 23 January 2013 14:25 CET Original file -
article html file updated 26 January 2013 09:26 CET Update -
article html file updated 29 January 2013 02:38 CET Update -
article html file updated 6 February 2013 06:58 CET Update -
article html file updated 7 February 2013 01:33 CET Update -
article html file updated 7 February 2013 11:33 CET Update -
article xml file uploaded 6 August 2013 16:03 CEST Original file https://www.mdpi.com/1424-8247/5/4/369/xml
article html file updated 6 August 2013 16:03 CEST Update -
article html file updated 16 June 2015 22:56 CEST Update -
article html file updated 25 March 2019 10:21 CET Update -
article html file updated 8 May 2019 19:07 CEST Update -
article html file updated 5 February 2020 19:59 CET Update https://www.mdpi.com/1424-8247/5/4/369/html
Back to TopTop